source
- AbbVie and Genmab's latest win brings Epkinly closer to label expansionAbbVie and Genmab’s bispecific antibody Epkinly succeeded in combination with a widely used cancer drug, bringing it one step closer to a potential label expansion in diffuse large B cell lymphoma.…Endpoints · 1mo ago↗ source
- Abivax aims to set cancer concerns with ulcerative colitis drug to restLate on Monday, Abivax released new trial data on its ulcerative colitis candidate, showing that cancer cases in a Phase 3 trial were within the expected range for these patients. The company says…Endpoints · 1mo ago↗ source
- Health AI caution crosses into confidenceHow people in health tech feel about AI in healthcare has changed drastically from just a year ago. Each year, health tech venture firm Venrock partners Bob Kocher, Bryan Roberts and Siobhan Nolan…